iCP-NI(Cellivery Therapeutics)

N/A

Report date: 2025/09/20 20:00:09
NME

Base Information

Drug NameiCP-NI(Cellivery Therapeutics)
Drug Alias NameCV-15
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNuclear factor NF-kappa-B complex modulators
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCellivery Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellivery Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A